Menu

bluebird bio, Inc. BLUE

Full chart Compare
Set alert

Price alert · BLUE

All alert types
4.97 0.00 (+0.00%)

At closeJun 2, 2025, 4:00 PM EDT

4.97 Day range 4.97

52-week range unavailable

YTD
-40.41%
1 year
-72.25%

Revenue & Expenses

Other Income → Expenses: $29.82MExpenses → Gross Loss: $5.57MExpenses → Selling, General & Admin: $167.87MExpenses → Research & Development: $94.25MExpenses → Other Operating Expenses: $2.76MExpenses → Income Tax: $70.00KNet Loss → Expenses: $240.72MRevenue → Cost of Revenue: $83.81MOther Income$29.82MNet Loss$240.72MCost of Revenue$89.38MExpenses$270.53MGross Loss$5.57MSelling, General & Admin$167.87MResearch & Development$94.25MOther Operating Expenses$2.76MIncome Tax$70.00KRevenue$83.81M

Latest period ending Dec 31, 2024 · select a line to chart its full history

BLUE annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
83.81M29.50M3.60M3.66M0
-5.57M-4.03M-6.48M-35.20M0
-270.46M-244.26M-250.19M-590.91M-559.26M
-240.72M-211.91M-230.34M-819.38M-618.70M
-24.84-38.59-58.60-237.80-199.00
BLUE annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
62.30M221.75M113.01M161.16M260.63M
460.23M619.16M569.81M593.79M1.78B
491.77M424.62M435.48M219.52M426.20M
354.87M330.33M367.06M89.58M65.42M
-31.53M194.54M134.33M374.28M1.36B
BLUE annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-260.02M-235.05M-316.22M-635.64M-470.35M
3.90M154.95M250.45M562.56M-84.34M
87.47M196.25M17.52M-93.95M546.72M
-2.60M88.74M93.79M-14.50M-28.99M
-168.65M116.15M-48.25M-167.04M-7.98M